JTT-705 5mg 5mg | Purity Not Available
Adooq Bioscience
JTT-705 (Dalcetrapib) is a CETP inhibitor.Inhibition of CETP is a target to increase HDL-cholesterol and potentially reduce atherosclerosis.
More Information Supplier PageJTT-705 (Dalcetrapib) is a CETP inhibitor.Inhibition of CETP is a target to increase HDL-cholesterol and potentially reduce atherosclerosis.
More Information Supplier PageJTT-705 (Dalcetrapib) is a CETP inhibitor.Inhibition of CETP is a target to increase HDL-cholesterol and potentially reduce atherosclerosis.
More Information Supplier PageJTT-705 (Dalcetrapib) is a CETP inhibitor.Inhibition of CETP is a target to increase HDL-cholesterol and potentially reduce atherosclerosis.
More Information Supplier PageJTT-705 (Dalcetrapib) is a CETP inhibitor.Inhibition of CETP is a target to increase HDL-cholesterol and potentially reduce atherosclerosis.
More Information Supplier PageBRL 52537 hydrochloride is a highly selective and potent ??-opioid agonist (Ki = 0.24 nM). 25 times more potent than morphine.
More Information Supplier PageBRL 52537 hydrochloride is a highly selective and potent ??-opioid agonist (Ki = 0.24 nM). 25 times more potent than morphine.
More Information Supplier PageBRL 52537 hydrochloride is a highly selective and potent ??-opioid agonist (Ki = 0.24 nM). 25 times more potent than morphine.
More Information Supplier PageBRL 52537 hydrochloride is a highly selective and potent ??-opioid agonist (Ki = 0.24 nM). 25 times more potent than morphine.
More Information Supplier PageLurasidone is an atypical antipsychotic that alleviates positive symptoms (e.g., hallucinations, delusions) without inducing extrapyramidal side effects except for akathisia,despite its potent D2 antagonistic actions.
More Information Supplier PageLurasidone is an atypical antipsychotic that alleviates positive symptoms (e.g., hallucinations, delusions) without inducing extrapyramidal side effects except for akathisia,despite its potent D2 antagonistic actions.
More Information Supplier Page